skip to Main Content

Starving Tumors of Important Amino Acid May Extend Survival in Pancreatic Cancer

Starving Tumors of Important Amino Acid May Extend Survival in Pancreatic Cancer
Investigators are evaluating whether eryaspase (Graspa), an L-asparaginase-based therapy that triggers tumor cell death, can extend survival for patients with pancreatic cancer. Patients with advanced pancreatic adenocarcinoma have few effective treatment options outside of a clinical trial or palliative care,1 and this could solve an unmet medical need.

“Patients [with pancreatic cancer] who progress after first-line therapy only really have 1 option, and that’s nanoliposomal irinotecan (Onivyde),” said Manuel Hidalgo, MD, PhD Read more . . . 


Back To Top